AI Verdict
HAE has stronger fundamentals based on our AI analysis.
HAVAR vs HAE Fundamental Comparison
| Metric | HAVAR | HAE |
|---|---|---|
| Revenue | N/A | $987.7M |
| Net Income | $729,121.0 | $117.5M |
| Net Margin | N/A | 11.9% |
| ROE | N/A | 12.9% |
| ROA | 0.5% | 4.7% |
| Current Ratio | 2.34x | 1.75x |
| Debt/Equity | N/A | 1.34x |
| EPS | $-0.02 | $2.46 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HAVAR vs HAE: Frequently Asked Questions
Is HAVAR or HAE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HAE has stronger fundamentals. HAVAR is rated SELL (74% confidence) while HAE is rated BUY (71% confidence). This is not investment advice.
How does HAVAR compare to HAE fundamentally?
Harvard Ave Acquisition Corp has ROE of N/A vs HAEMONETICS CORP's 12.9%. Net margins are N/A vs 11.9% respectively.
Which stock pays higher dividends, HAVAR or HAE?
HAVAR has a dividend yield of N/A or no dividend while HAE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HAVAR or HAE for long term?
For long-term investing, consider that HAVAR has SELL rating with 74% confidence, while HAE has BUY rating with 71% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HAVAR vs HAE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HAVAR vs HAE, the AI consensus favors HAE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.